All News

As Ekterly nears the one-year anniversary of its approval, Chiesi Group is making moves to acquire the rare di…

Eli Lilly’s latest attempt to strengthen its genetic medicine offering has seen the pharma team up with Proflu…

A new KFF survey of state Medicaid officials and focus groups in eight states captures the different choices s…

At Wednesday's argument, the justices did not appear to question whether skinny labeling is valid.…

…

A Jefferies analyst argued the deal — Teva’s largest in a decade — “makes se…

Results show a landmark change that could double survival rates in one of the most difficult oncology diagnose…

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in …

Eleventh-hour settlements with two of the three generic drugmakers involved could bode well for both Pfizer an…

…

A few years in, admin tech is still reigning as the king of health tech funding. Startups using AI to tackle m…

When the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the …

Survodutide spurred weight loss Wall Street analysts referred to as “Wegovy-like,” and showed sign…

The Supreme Court Wednesday will hear oral arguments about a simmering controversy over so-called skinny label…

The large AI player is paying $400 million for the tiny startup, signaling a potential shift in how tech is ap…

Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its ac…

Oruka Therapeutics’ long-acting plaque psoriasis candidate cleared the skin of 63.5% of patients in a phase 2a…

The Supreme Court seemed divided Monday over whether to block thousands of lawsuits alleging the maker of the …

Veradermics has succeeded in its first major test as a newly-minted public company. The biotech's form of oral…

Merck & Co.’s $1 billion deal with Google Cloud is seeking to bolster its AI credentials—and the U.S. Big …